Exclusive: GSK set for Human Genome Sciences takeover – sources

Previous Post: nbsp

Exclusive: GSK set for Human Genome Sciences takeover – sources

Reuters – GlaxoSmithKline is expected to announce a deal to buy Human Genome Sciences for about $2.8 billion as soon as Monday, ending a three-month hostile pursuit of the U.S. biotech company on friendly terms after sweetening its offer. Sources familiar with the situation said Britain’s biggest drugmaker was set to pay around $14 per share, up from $13 offered previously, which Human Genome – an early pioneer of gene-based drug discovery – had rejected as inadequate. Read article

Tags: ,

Views: 0

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes